[HTML][HTML] Zerumbone ameliorates behavioral impairments and neuropathology in transgenic APP/PS1 mice by suppressing MAPK signaling

L Li, XH Wu, XJ Zhao, L Xu, CL Pan… - Journal of …, 2020 - Springer
Background Alzheimer's disease (AD) is a major clinical problem, but there is a distinct lack
of effective therapeutic drugs for this disease. We investigated the potential therapeutic …

[HTML][HTML] Zerumbone ameliorates behavioral impairments and neuropathology in transgenic APP/PS1 mice by suppressing MAPK signaling

L Li, XH Wu, XJ Zhao, L Xu, CL Pan… - Journal of …, 2020 - ncbi.nlm.nih.gov
Background Alzheimer's disease (AD) is a major clinical problem, but there is a distinct lack
of effective therapeutic drugs for this disease. We investigated the potential therapeutic …

[引用][C] Zerumbone ameliorates behavioral impairments and neuropathology in transgenic APP/PS1 mice by suppressing MAPK signaling

L Li, XH Wu, XJ Zhao, L Xu… - Journal of …, 2020 - tobias-lib.ub.uni-tuebingen.de
Zerumbone ameliorates behavioral impairments and neuropathology in transgenic APP/PS1 mice
by suppressing MAPK signaling Zerumbone ameliorates behavioral impairments and …

[引用][C] Zerumbone ameliorates behavioral impairments and neuropathology in transgenic APP/PS1 mice by suppressing MAPK signaling

L Li, XH Wu, XJ Zhao, L Xu, CL Pan… - Journal of …, 2020 - ub01.uni-tuebingen.de
Zerumbone ameliorates behavioral impairments and neuropathology in transgenic APP/PS1 mice
by suppressing MAPK signaling Zerumbone ameliorates behavioral impairments and …

[HTML][HTML] Zerumbone ameliorates behavioral impairments and neuropathology in transgenic APP/PS1 mice by suppressing MAPK signaling

L Li, XH Wu, XJ Zhao, L Xu… - Journal of …, 2020 - jneuroinflammation.biomedcentral …
Alzheimer's disease (AD) is a major clinical problem, but there is a distinct lack of effective
therapeutic drugs for this disease. We investigated the potential therapeutic effects of …

Zerumbone ameliorates behavioral impairments and neuropathology in transgenic APP/PS1 mice by suppressing MAPK signaling.

L Li, XH Wu, XJ Zhao, L Xu, CL Pan, ZY Zhang - 2020 - cabidigitallibrary.org
Background: Alzheimer's disease (AD) is a major clinical problem, but there is a distinct lack
of effective therapeutic drugs for this disease. We investigated the potential therapeutic …

Zerumbone ameliorates behavioral impairments and neuropathology in transgenic APP/PS1 mice by suppressing MAPK signaling

L Li, XH Wu, XJ Zhao, L Xu, CL Pan… - Journal of …, 2020 - go.gale.com
Background Alzheimer's disease (AD) is a major clinical problem, but there is a distinct lack
of effective therapeutic drugs for this disease. We investigated the potential therapeutic …

Zerumbone ameliorates behavioral impairments and neuropathology in transgenic APP/PS1 mice by suppressing MAPK signaling

L Li, XH Wu, XJ Zhao, L Xu, CL Pan, ZY Zhang - 2020 - search.proquest.com
Background Alzheimer's disease (AD) is a major clinical problem, but there is a distinct lack
of effective therapeutic drugs for this disease. We investigated the potential therapeutic …

Zerumbone ameliorates behavioral impairments and neuropathology in transgenic APP/PS1 mice by suppressing MAPK signaling

L Li, XH Wu, XJ Zhao, L Xu… - Journal of …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Alzheimer's disease (AD) is a major clinical problem, but there is a distinct lack
of effective therapeutic drugs for this disease. We investigated the potential therapeutic …

Zerumbone ameliorates behavioral impairments and neuropathology in transgenic APP/PS1 mice by suppressing MAPK signaling.

L Li, XH Wu, XJ Zhao, L Xu, CL Pan… - Journal of …, 2020 - search.ebscohost.com
Abstract < bold> Background: </bold> Alzheimer's disease (AD) is a major clinical
problem, but there is a distinct lack of effective therapeutic drugs for this disease. We …